Atezolizumab

ATC L01FF05 · 12 markets · 48 records

Atezolizumab 12 markets · 48 records Forms
Filters
Kind

AU 8 records · 6 shown of 6 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

Only this ingredient

  • 1,200 mg/20 mLinjectionTECENTRIQ also in GB·US·FR
    +1Other 1 marketsCN
  • 840 mg/14 mLinjectionTECENTRIQ also in GB·US·SG
    +1Other 1 marketsFR
  • 1,875 mg/15 mLinjectionTECENTRIQ SC also in GB·SG
  • 1,875 mginjectionTECENTRIQ SC atezolizumab 1875 mg/15 mL solution for injection vial also in ES·FR unknown
  • 1,200 mginjectionTECENTRIQ atezolizumab (rch) 1200 mg/20 mL injection concentrated vial also in SG unknown
  • 840 mginjectionTECENTRIQ atezolizumab (rch) 1200 mg/20 mL injection concentrated vial also in ES unknown
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名TECENTRIQ ×2TECENTRIQ SC ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

ES 8 records · 3 shown of 3 Source CIMA (AEMPS) · Data as of live

Only this ingredient

GB 7 records · 4 shown of 4 Source NHSBSA dm+d · Data as of 2026-10-19

Only this ingredient

HK 4 records · 0 shown of 0 Source 衞生署藥物辦公室(香港)註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

4 records · 0 manufacturers 4 registros · 0 fabricantes 4 个记录 · 0 个厂家 4 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名TECENTRIQ CONCENTRATE FOR SOLUTION FOR INFUSION 840MG/14ML ×9Tecentriq Solution for Subcutaneous Injection ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

US 3 records · 3 shown of 3 Source openFDA NDC Directory · Data as of 2026-10-23

Only this ingredient

Combination products containing this ingredient

  • 1,875 mg/15 mLinjection CombinationAtezolizumab 1,875 mg/15 mL + Hyaluronidase (Human Recombinant) 30,000 unit/15 mLTecentriq Hybreza

CA 3 records · 2 shown of 2 Source Health Canada Drug Product Databas · Data as of 2026-10-23

Only this ingredient

SG 3 records · 3 shown of 3 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

Only this ingredient

FR 3 records · 3 shown of 3 Source Base de données publique des médic · Data as of 2026-11-03

Only this ingredient

TW 2 records · 0 shown of 0 Source 衛生福利部食品藥物管理署(TFDA)全部藥品許可證資料集 · Data as of 2026-10-22 · some records have no stated strength

2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名TECENTRIQ ×2Tecentriq Solution for Subcutaneous Injection ×2癌自禦 注射劑 ×1癌自禦皮下注射劑 ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

CN 1 records · 1 shown of 1 Source 国家医保局 医保药品分类与代码数据库 · Data as of 2025-04-04

Only this ingredient

  • 1,200 mg/20 mLinjection泰圣奇阿替利珠单抗 also in AU·GB·US
    +1Other 1 marketsFR

MX 1 records · 0 shown of 0 Source COFEPRIS · Data as of annual · some records have no stated strength

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名TECENTRIQ SC ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

Side-by-side table

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.